These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38149505)

  • 41. Ferroptosis-Driven Nanotherapeutics to Reverse Drug Resistance in Tumor Microenvironment.
    Zhu L; Meng D; Wang X; Chen X
    ACS Appl Bio Mater; 2022 Jun; 5(6):2481-2506. PubMed ID: 35614872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs.
    Su Y; Zhao B; Zhou L; Zhang Z; Shen Y; Lv H; AlQudsy LHH; Shang P
    Cancer Lett; 2020 Jul; 483():127-136. PubMed ID: 32067993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Redox Homeostasis Disruptors Based on Metal-Phenolic Network Nanoparticles for Chemo/Chemodynamic Synergistic Tumor Therapy through Activating Apoptosis and Cuproptosis.
    Zhao F; Yu H; Liang L; Wang C; Shi D; Zhang X; Ying Y; Cai W; Li W; Li J; Zheng J; Qiao L; Che S; Yu J
    Adv Healthc Mater; 2023 Nov; 12(29):e2301346. PubMed ID: 37369362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Iron ion and sulfasalazine-loaded polydopamine nanoparticles for Fenton reaction and glutathione peroxidase 4 inactivation for enhanced cancer ferrotherapy.
    Zhu X; Chen Q; Xie L; Chen W; Jiang Y; Song E; Song Y
    Acta Biomater; 2022 Jun; 145():210-221. PubMed ID: 35470077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Role of Iron Metabolism, Lipid Metabolism, and Redox Homeostasis in Alzheimer's Disease: from the Perspective of Ferroptosis.
    Wu L; Xian X; Tan Z; Dong F; Xu G; Zhang M; Zhang F
    Mol Neurobiol; 2023 May; 60(5):2832-2850. PubMed ID: 36735178
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting ferroptosis in rhabdomyosarcoma cells.
    Dächert J; Ehrenfeld V; Habermann K; Dolgikh N; Fulda S
    Int J Cancer; 2020 Jan; 146(2):510-520. PubMed ID: 31173656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Self-engineered binary nanoassembly enabling closed-loop glutathione depletion-amplified tumor ferroptosis.
    Lei J; Zhang S; Wu Z; Sun X; Zhou B; Huang P; Fang M; Li L; Luo C; He Z
    Biomater Sci; 2023 Nov; 11(22):7373-7386. PubMed ID: 37791561
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An ROS-Activatable Nanoassembly Remodulates Tumor Cell Metabolism for Enhanced Ferroptosis Therapy.
    Zhang Y; Li L; Li Y; Fei Y; Xue C; Yao X; Zhao Y; Wang X; Li M; Luo Z
    Adv Healthc Mater; 2022 Jan; 11(2):e2101702. PubMed ID: 34710950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unlocking the anticancer activity of gambogic acid: a shift towards ferroptosis via a GSH/Trx dual antioxidant system.
    Lan J; Liu L; Zhao W; Li Z; Zeng R; Fang S; Chen L; Shen Y; Wei H; Zhang T; Ding Y
    Free Radic Biol Med; 2024 Jun; 218():26-40. PubMed ID: 38570172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biodegradable Amorphous Copper Iron Tellurite Promoting the Utilization of Fenton-Like Ions for Efficient Synergistic Cancer Theranostics.
    Liu H; Jiang R; Lu Y; Shan B; Wen Y; Li M
    ACS Appl Mater Interfaces; 2022 Jun; 14(25):28537-28547. PubMed ID: 35704874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ferroptosis is involved in trophoblast cells cytotoxicity induced by black phosphorus nanoparticles.
    You R; Mu Y; Zhou J; Wang C; Fang Z; Liu Y; Liu S; Zhai Q; Zhang C
    Toxicology; 2024 Jun; 505():153810. PubMed ID: 38653377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A new therapeutic perspective: Erastin inhibits tumor progression by driving ferroptosis in myelodysplastic syndromes.
    Li J; Ma J; Zhang R; Zhai Y; Zhang W; Fu R
    J Investig Med; 2024 Jun; 72(5):414-424. PubMed ID: 38557364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elesclomol-copper synergizes with imidazole ketone erastin by promoting cuproptosis and ferroptosis in myelodysplastic syndromes.
    Gao Y; Jin F; Zhang P; Zheng C; Zheng X; Xie J; Lu Y; Tong X; Du J; Zhang J; Wang Y
    Biomed Pharmacother; 2024 Jun; 175():116727. PubMed ID: 38733771
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Iron accumulation, glutathione depletion, and lipid peroxidation must occur simultaneously during ferroptosis and are mutually amplifying events.
    Bertrand RL
    Med Hypotheses; 2017 Apr; 101():69-74. PubMed ID: 28351498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Self-Adaptive Single-Atom Catalyst Boosting Selective Ferroptosis in Tumor Cells.
    Cao F; Sang Y; Liu C; Bai F; Zheng L; Ren J; Qu X
    ACS Nano; 2022 Jan; 16(1):855-868. PubMed ID: 35025200
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Triggered All-Active Metal Organic Framework: Ferroptosis Machinery Contributes to the Apoptotic Photodynamic Antitumor Therapy.
    Meng X; Deng J; Liu F; Guo T; Liu M; Dai P; Fan A; Wang Z; Zhao Y
    Nano Lett; 2019 Nov; 19(11):7866-7876. PubMed ID: 31594301
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mild-Photothermal Effect Induced High Efficiency Ferroptosis-Boosted-Cuproptosis Based on Cu
    Chen W; Xie W; Gao Z; Lin C; Tan M; Zhang Y; Hou Z
    Adv Sci (Weinh); 2023 Nov; 10(33):e2303694. PubMed ID: 37822154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multienzyme-like Reactivity Cooperatively Impairs Glutathione Peroxidase 4 and Ferroptosis Suppressor Protein 1 Pathways in Triple-Negative Breast Cancer for Sensitized Ferroptosis Therapy.
    Li K; Lin C; Li M; Xu K; He Y; Mao Y; Lu L; Geng W; Li X; Luo Z; Cai K
    ACS Nano; 2022 Feb; 16(2):2381-2398. PubMed ID: 35041395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Strategy of Fenton Reaction Cycloacceleration for High-Performance Ferroptosis Therapy Initiated by Tumor Microenvironment Remodeling.
    Huang L; Feng J; Zhu J; Yang J; Xiong W; Lu X; Chen S; Yang S; Li Y; Xu Y; Shen Z
    Adv Healthc Mater; 2023 Jul; 12(18):e2203362. PubMed ID: 36893770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Iron nitroprusside as a chemodynamic agent and inducer of ferroptosis for ovarian cancer therapy.
    Asif K; Adeel M; Rahman MM; Caligiuri I; Perin T; Cemazar M; Canzonieri V; Rizzolio F
    J Mater Chem B; 2023 Apr; 11(14):3124-3135. PubMed ID: 36883303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.